Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01018901 · ClinicalTrials.gov registry record · NA
Goals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer Treatment
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01018901: Completed NA study, sponsored by Abramson Cancer Center at Penn Medicine.
NCT01018901 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01018901, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about survivors of prostate cancer and their partners may help doctors learn more about the goals for sexual functioning after cancer treatment. PURPOSE: This clinical trial is studying the goals of sexual functioning in prostate cancer survivors and their partners after cancer treatment.
Interventions
- OTHER Survey Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-01 |
| Est. Completion | 2013-12-31 |
| Phase | NA |
What the finished NCT01018901 record still lists
NCT01018901 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Survey Administration is the first listed.
NCT01018901 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01018901 about?
NCT01018901 is a clinical study titled "Goals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer Treatment". RATIONALE: Gathering information about survivors of prostate cancer and their partners may help doctors learn more about the goals for sexual functioning after cancer treatment. PURPOSE: This clinical trial is studying the goals of sexual functioning in prostate cancer survivors and their partners a...
What is the current status of trial NCT01018901?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2009-01. Estimated completion is 2013-12-31.
What interventions are being tested in trial NCT01018901?
The interventions under investigation include: Survey Administration (OTHER).
Who is sponsoring clinical trial NCT01018901?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01018901's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia